13D/13G Filings - GKCC LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-09-27
9:36 pm
Purchase		2024-06-0713GXilio Therapeutics, Inc.
XLO		GKCC LLC7,000,000
15.900%		7,000,000increase
(New Position)		Filing
History
2024-08-14
5:01 pm
Purchase		2024-08-1213DElicio Therapeutics, Inc.
ELTX		GKCC LLC5,595,108
38.700%		3,442,341increase
(+159.90%)		Filing
History
2024-07-02
4:39 pm
Purchase		2024-06-2813DElicio Therapeutics, Inc.
ELTX		GKCC LLC2,152,767
19.990%		109,587increase
(+5.36%)		Filing
History
2024-05-22
4:33 pm
Purchase		2024-05-1413GMiNK Therapeutics, Inc.
INKT		GKCC LLC464,000
11.790%		464,000increase
(New Position)		Filing
History
2024-03-20
4:37 pm
Purchase		2024-03-1913DElicio Therapeutics, Inc.
ELTX		GKCC LLC2,043,180
19.990%		123,016increase
(+6.41%)		Filing
History
2023-12-26
4:25 pm
Purchase		2023-12-2213DElicio Therapeutics, Inc.
ELTX		GKCC LLC1,920,164
19.990%		1,213,000increase
(+171.53%)		Filing
History
2023-09-22
4:17 pm
Purchase		2023-09-2213GNascent Biotech, Inc.
NBIO		GKCC LLC10,000,000
6.300%		10,000,000increase
(New Position)		Filing
History
2023-08-30
4:15 pm
Purchase		2023-08-2113DImmix Biopharma, Inc.
IMMX		GKCC LLC3,255,734
19.990%		3,255,734increase
(New Position)		Filing
History
2023-06-14
2:42 pm
Purchase		2023-06-0113DElicio Therapeutics, Inc.
ELTX		GKCC LLC707,164
8.400%		707,164increase
(New Position)		Filing
History